NEWS

05.09.2014

Allergopharma GmbH & Co. KG Celebrates Topping Out Ceremony

Topping Out Ceremony for new €40 million production facility Allergopharma celebrates 45-year anniversary

...read more

05.09.2014

Allergopharma and S-TARget therapeutics conclude licensing agreement

Objective is new generation of therapeutics for allergy treatment

...read more

01.07.2014

Largest European allergy congress announced latest research approaches

This year the most important European congress, the "European Academy of Allergy and Clinical Immunology" (EAACI), took place in Copenhagen...

...read more

11.06.2014

Consortium supports GA²LEN in the development of mobile environmental exposure chambers

The Global Asthma and Allergy European Network (GA²LEN) together with three allergen immunotherapy companies – Allergopharma, Laboratorios...

...read more

15.05.2014

Top Management Change at Allergopharma

Marco Linari (43) became CEO of Allergopharma, the global Allergy business unit of the Merck Group. He succeeded Uta Kemmerich-Keil, who...

...read more

21.01.2014

Allergopharma invests € 40 million in production facility

The German pharmaceutical, chemical and life science company Merck broke ground today on a new production facility for its Allergopharma...

...read more

Displaying results ###SPAN_BEGIN###%s to %s out of ###SPAN_BEGIN###%s
<< First < Previous 1-7 8-13 Next > Last >>

Service Downloads


Cooperations, Sponsorships & Partnerships